Researchers enrolled approximately 250 patients in a randomized clinical trial for the medication adherence intervention, which consisted on medication reconciliation and customization from a pharmacist, patient education, collaboration between a patient’s pharmacist and primary care provider and cardiologist and reminder messaging.
In general, a year after discharge, 89.3 percent of patients were medication adherent, compared with 73.9 percent compliance in the control group. The intervention showed particular benefits for blood thinners and statins but not beta blockers.
While medication adherence differed between the groups, both had statistically similar proportions of patients who achieved blood pressure and cholesterol targets over the course of the intervention period.
Researchers concluded more research is needed into the relationship between medication adherence and improved clinical outcomes.
More Articles on Quality:
Study: Team-Based Care Faces Barriers to Success
Sentara Healthcare Opens Copper-Infused Wing to Reduce HAIs
Study: Lean Sigma Six Fits Surgical Interventions
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
